作者: Lídia Cunha , Krisztián Szigeti , Domokos Mathé , Luís F. Metello
DOI: 10.1016/J.DRUDIS.2014.01.003
关键词:
摘要: Drug development represents a highly complex, inefficient and costly process. Over the past decade, widespread use of nuclear imaging, owing to its functional molecular nature, has proven be determinant in improving efficiency selecting candidate drugs that should either abandoned or moved forward into clinical trials. This helps not only with safer effective but also shortening time-to-market. The modern concept future trends concerning imaging will assumedly hybrid multimodality including combinations between high sensitivity (molecular) modalities spatial resolution morphological techniques.